Medindia

X

Aurobindo Pharma Gets US FDA Nod for Donepezil Hydrochloride Tablets

by Dr. Trupti Shirole on  June 2, 2011 at 3:43 PM Drug News   - G J E 4
The US Food and Drug Administration (US FDA) has given its final approval to Aurobindo Pharma Ltd. for 5mg and 10mg Donepezil Hydrochloride tablets.
 Aurobindo Pharma Gets US FDA Nod for Donepezil Hydrochloride Tablets
Aurobindo Pharma Gets US FDA Nod for Donepezil Hydrochloride Tablets
Advertisement

These tablets are generically equivalent to Aricept tablets (sold by Eisai Medical Research Inc. in partnership with Pfizer) and fall under the Central Nervous System therapeutic segment that are meant for the treatment of mild, moderate and severe dementia and Alzheimer's disease.

Advertisement
The product had a market size of approximately USD 2.5 billion for the twelve months ended September 2010, according to IMS.


Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: